Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials - Top-Institutions - MDSpire

Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials

  • By

  • Shuo Zhao

  • Miaoqin Wu

  • Jingxiang Zhong

  • Baihua Chen

  • Zongming Song

  • Zhang Ming

  • Quanhong Han

  • Suqin Yu

  • Hong Wang

  • Songtao Yuan

  • Jin Yao

  • Mingwei Zhao

  • Xiaohong Meng

  • Feng Wang

  • Jing Lou

  • Yanli Liu

  • Haomin Huang

  • Qinghong Zhou

  • Yuyu Xu

  • Hong Dai

  • Xiaorong Li

  • July 1, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, Florida

    Key Differentiators

    • Ophthalmology
  • #2

    Wilmer Eye Institute, Johns Hopkins Medicine
    Wilmer Eye Institute, Johns Hopkins Medicine

    Baltimore, Maryland

    Key Differentiators

    • Ophthalmology
  • #3

    National Eye Institute
    National Eye Institute

    Bethesda, Maryland

    Key Differentiators

    • Ophthalmology
  • #4

    The New York Eye and Ear Infirmary
    The New York Eye and Ear Infirmary

    New York, New York

    Key Differentiators

    • Ophthalmology
  • #5

    Ophthalmic Consultants of Boston
    Ophthalmic Consultants of Boston

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology

Original Source(s)

Related Content